Your Partner in Oligonucleotide Supply
As effective oligonucleotide APIs continue to emerge for a broad range of therapeutic indications, it is important to select a supplier with with the experience and technology to help support this rapid growth sector of the industry.
Our approach leverages decades of CDMO experience in peptide manufacturing and a wide range of existing downstream capabilities at multiple facilities. We provide oligonucleotide process development, scale-up and cGMP manufacturing at multiple scales, supporting early stage development to Phase II / III clinical supply (with commercial supply expected by the end of 2025).
Platform Capabilities
- Extensive process & analytical development capabilities in an FDA-approved facility
- Development & proof of concept via OligosyntTM units (10 umol to 12 mmol)
- Small-scale to mid-scale GMP synthesis capabilities via multiple OligoPilotTM units (10-100 mmol)
- Larger scale synthesis capabilities via OligoProcessTM unit
- Common equipment platform ensures smooth scale-up & transition from development to manufacturing
- Extensive downstream processing equipment such as chromatography skids, ultrafiltration equipment & lyophilization
Your Benefits > Our Strengths
1) Focus on Patient Safety > Our Motto is Quality
Rely on the integrity of our robust quality and regulatory compliance standards at the foundation of every step your project takes, from initial process development through product delivery and beyond.
2) Foster Entrepreneurial Spirit > Flexibility and Transparency
Benefit from our collaborative commitment to react with flexibility and transparency to your changing needs.
3) Faster Time to Market with reduced costs > Streamlined Fully Integrated Supply
Discover how our fully integrated supply services, ranging from drug substance, fill and finish drug products and packaging, enable faster times to clinical trials and commercial markets with reduced costs.
Downloads
Seamless Integration Across the Supply Chain
Working and coordinating with several providers can be demanding and time-consuming when outsourcing a project. Our aim is to streamline your process, improve efficiency and reduce costs by consolidating multiple services in one organization.
As your CDMO partner, we work alongside you to understand and anticipate your project needs. We deliver them through seamlessly integrated technologies and services from across our expert global network that support the development and manufacture of pharmaceutical and biotech innovators’ complex modalities. Our bespoke end-to-end solutions span your supply chain, covering all stages from drug development to commercialization.
Want to find out more?
Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.